FoxRJThompsonABakerD. Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS. Mult Scler2012;18: 1534–1540.
2.
KodamaSSaitoKTanakaS. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: A meta-analysis. JAMA2009; 301: 2024–2035.
3.
DayJRRossiterHBCoatsEM. The maximally attainable VO2 during exercise in humans: The peak vs. maximum issue. J Appl Physiol2003; 95: 1901–1907.
4.
CastellanoVPatelDIWhiteLJ. Cytokine responses to acute and chronic exercise in multiple sclerosis. J Appl Physiol2008; 104: 1697–1702.
5.
CressMEMeyerM. Maximal voluntary and functional performance levels needed for independence in adults aged 65 to 97 years. Phys Ther2003; 83: 37–48.
6.
BaertIFreemanJSmedalT. Responsiveness and clinically meaningful improvement, according to disability level, of five walking measures after rehabilitation in multiple sclerosis: A European multi-center study. Neurorehabil Neural Repair (in press).
7.
RaoSMLeoGJEllingtonL. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology1991; 41: 692–696.
8.
SumowskiJFLeavittVMCohenA. Retrieval practice is a robust memory aid for memory-impaired patients with MS. Mult Scler2013; 19: 1943–1946.
9.
SonderJMBurggraaffJKnolDL. Comparing long-term results of PASAT and SDMT scores in relation to neuropsychological testing in multiple sclerosis. Mult Scler. [Epub ahead of print 9; September 2013].
10.
FeinsteinA. Multiple sclerosis and depression. Mult Scler2011; 17: 1276–1281.
